Educational background

2013.09-2015.07 Chinese Center for Disease Control and Prevention, PhD

2010.09-2013.07 Chinese Center for Disease Control and Prevention, M.S.

2004.09-2008.07 Wuhan University, B.S.

Work experience

2021.8-present Associate Professor, School of Public Health, Xiamen University

2017.10-2021.7 Assistant Professor, School of Public Health, Xiamen University

2015.07-2017.08 Postdoctoral Fellow, School of Public Health, Xiamen University

Main research areas

Focus on Clinical Trials of Innovative Vaccines and Epidemiological Studies of Infectious Diseases：human papillomavirus (HPV) vaccine series clinical studies and related epidemiological studies; intranasal spray SARS-CoV-2 vaccine dNS1-RBD clinical studies and related epidemiological studies; Hepatitis E vaccine clinical studies and epidemiological studies of Hepatitis E; varicella vaccine/herpes zoster vaccine clinical studies and epidemiological studies of varicella.

Selected Publications in past 3 years：

[1] Shoujie Huang^(#), Xuefeng Zhang^(#), Yingying Su^(#), Chunlan Zhuang^(#), Zimin Tang^(#), Xingcheng Huang, Qi Chen, Kongxin Zhu, Xiaowen Hu, Dong Ying, Xiaohui Liu, Hanmin Jiang, Xia Zang, Zhongze Wang, Changlin Yang, Donglin Liu, Yijun Wang, Quan Tang, Wentong Shen, Huanhuan Cao, Huirong Pan, Shengxiang Ge, Yue Huang, Ting Wu^(*), Zizheng Zheng^(*), Fengcai Zhu^(*), Jun Zhang^(*)and Ningshao Xia^(*). Long-term efficacy of a recombinant hepatitis E vaccine in adults: 10-year results from a randomised, placebo-controlled, phase 3 trial. Lancet. 2023, Accept. (co-first author)

[2] Fengcai Zhu^(#), Shoujie Huang^(#), Xiaohui Liu^(#), Qi Chen^(#), Chunlan Zhuang^(#), Hui Zhao^(#), Jinle Han^(#), Anjuli May Jaen, Thai Hung Do, Jonathan Grant Peter, Alexander Gonzalez Dorado, Louie S Tirador, Gelza Mae A Zabat, Ralph Elvi M Villalobos, Gemalyn Pineda Gueco, Lauren Livia Greta Botha, Shirley Patricia Iglesias Pertuz, Jiaxiang Tan, Kongxin Zhu, Jiali Quan, Hongyan Lin, Yue Huang, Jizong Jia, Xiafei Chu, Junyu Chen, Yixin Chen, Tianying Zhang^(*), Yingying Su^(*), Changgui Li^(*), Xiangzhong Ye^(*), Ting Wu^(*), Jun Zhang^(*), Ningshao Xia^(*), Safety and efficacy of the intranasal spray SARS-CoV-2 vaccine dNS1-RBD: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. Lancet Respir Med. 2023, 11(12):1075-1088. (co-corresponding author)

[3] Feng-Cai Zhu^(#), Guo-Hua Zhong^(#), Wei-Jin Huang^(#) , Kai Chu 1, Li Zhang , Zhao-Feng Bi , Kong-Xin Zhu , Qi Chen , Ting-Quan Zheng , Ming-Lei Zhang , Sheng Liu , Jin-Bo Xu , Hong-Xing Pan 1, Guang Sun , Feng-Zhu Zheng , Qiu-Fen Zhang , Xiu-Mei Yi , Si-Jie Zhuang , Shou-Jie Huang , Hui-Rong Pan^(*) , Ying-Ying Su^(*) , Ting Wu^(*) , Jun Zhang^(*) , Ning-Shao Xia^(*). Head-to-head immunogenicity comparison of an Escherichia coli-produced 9-valent human papillomavirus vaccine and Gardasil 9 in women aged 18-26 years in China: a randomised blinded clinical trial. Lancet Infect Dis. 2023, 23(11):1313-1322.（co-corresponding author）

[4] Lingxian Qiu^(#), Sheng Liu^(#), Minglei Zhang^(#), Guohua Zhong, Siying Peng, Jiali Quan, Hongyan Lin, Xiaowen Hu, Kongxin Zhu, Xingcheng Huang, Junchao Peng, Yue Huang, Shoujie Huang, Ting Wu, Jinbo Xu, Zifang Dong, Qi Liang^(*), Wei Wang^(*), Yingying Su^(*), Jun Zhang & Ningshao Xia. The epidemiology of varicella and effectiveness of varicella vaccine in Ganyu, China: a long-term community surveillance study. BMC Public Health. 2023, 23(1):1875 （co-corresponding author）

[5] Qi Chen, Kongxin Zhu, Xiaohui Liu, Chunlan Zhuang, Xingcheng Huang, Yue Huang, Xingmei Yao, Jiali Quan, Hongyan Lin, Shoujie Huang, Yingying Su^(*), Ting Wu^(*), Jun Zhang, Ningshao Xia. The Protection of Naturally Acquired Antibodies Against Subsequent SARS-CoV-2 Infection: A Systematic Review and Meta-Analysis. Emerg Microbes Infect. 2022; 11: 793-803. (co-corresponding author)

[6] Huang ZH, Lu GY, Qiu LX, Zhong GH, Huang Y, Yao XM, Liu XH, Huang SJ, Wu T, Yuan Q, Wang YB^(*), Su YY^(*), Zhang J, Xia NS. Risk of hepatocellular carcinoma in antiviral treatment-naive chronic hepatitis B patients treated with entecavir or tenofovir disoproxil fumarate: a network meta-analysis. BMC Cancer. 2022; 22: 287. (co-corresponding author)

[7] Sun YP^(#), Zheng XY^(#), Zhang HX, Zhou XM, Lin XZ, Zheng ZZ, Zhang J, Su YY^(*), Zhou YL^(*). Epidemiology of Respiratory Pathogens Among Children Hospitalized for Pneumonia in Xiamen: A Retrospective Study. Infect Dis Ther. 2021, 10(3):1567-1578 (co-corresponding author)

[8] Wei FX^(#), Su YY^(#), Cui XL, Yu XJ, Li YF, Song QQ, Yin K, Huang SJ, Li MQ, Zhang J, Wu T^(*), Xia N. Sequential Acquisition of Human Papillomavirus Infection at Genital and Anal Sites, Liuzhou, China. Emerg Infect Dis. 2020, 26(10):2387-2393 (co-first author)

[9] Li W^(#), Su Y-Y^(#), Zhi S-S^(#), Huang J, Zhuang C-L, Bai W-Z, Wan Y, Meng X-R, Zhang L, Zhou Y-B, Luo Y-Y, Ge S-X^(*), Chen Y-K^(*), Ma Y^(*), Viral shedding dynamics in asymptomatic and mildly symptomatic patients infected with SARS-CoV-2, Clin Microbiol Infect. 2020, 26(11):1556.e1-1556.e6. (co-first author)

[10] Bin Lou^(#), Ting-Dong Li^(#), Shu-Fa Zheng^(#), Ying-Ying Su^(#), Zhi-Yong Li, Wei Liu, Fei Yu, Sheng-Xiang Ge^(*), Qian-Da Zou, Quan Yuan, Sha Lin, Cong-Ming Hong, Xiang-Yang Yao, Xue-Jie Zhang, Ding-Hui Wu, Guo-Liang Zhou, Wang-Heng Hou, Ting-Ting Li, Ya-Li Zhang, Shi-Yin Zhang, Jian Fan^(*), Jun Zhang^(*), Ning-Shao Xia, Yu Chen^(*). Serology characteristics of SARS-CoV-2 infection since exposure and post symptom onset. Eur Respir J. 2020, 56(2):2000763. (co-first author)

[11] Hong-Jun Zhang^(#) , Ying-Ying Su^(#) , Shi-Lin Xu^(#) , Guo-Qing Chen, Chang-Cheng Li, Ren-Jie Jiang, Rong-Hai Liu, Sheng-Xiang Ge^(*), Jun Zhang, Ning-Shao Xia, Tang Quan^(*). Asymptomatic and Symptomatic SARS-CoV-2 Infections in Close Contacts of COVID-19 Patients: A Seroepidemiological Study. Clin Infect Dis. 2021, 73(3):553-554 (co-first author)

[12] Juanjuan Zhao^(#), Quan Yuan^(#), Haiyan Wang ^(#),Wei Liu^(#), Xuejiao Liao^(#), Yingying Su^(#), Xin Wang, Jing Yuan, Tingdong Li, Jinxiu Li, Shen Qian, Congming Hong, Fuxiang Wang, Yingxia Liu, Zhaoqin Wang, Qing He, Zhiyong Li, Bin He, Tianying Zhang, Yang Fu, Shengxiang Ge^(*), Lei Liu^(*) , Jun Zhang^(*), Ningshao Xia, Zheng Zhang^(*). Antibody responses to SARS-CoV-2 in patients of novel coronavirus disease 2019. Clin Infect Dis. 2020, 71(16):2027-2034. (co-first author)

[13] Lihui Wei^(#), Yingying Su^(#), Yuemei Hu, Rongcheng Li, Wen Chen, Qinjing Pan, Xun Zhang, Fanghui Zhao, Yuqian Zhao, Qing Li, Ying Hong, Chao Zhao, Mingqiang Li, Wenyu Liu, Caihong Li, Dongping Guo, Lidong Ke, Bizhen Lin, Zhijie Lin, Shu Chen, Wei Sheng, Zizheng Zheng, Sijie Zhuang, Fengcai Zhu, Huirong Pan, Yimin Li, Shoujie Huang, Jun Zhang(*), Youlin Qiao(*), Ting Wu(*), Ningshao Xia. Age distribution of human papillomavirus infection and neutralizing antibodies in healthy Chinese women aged 18-45 years enrolled in a clinical trial. Clin Microbiol Infect. 2020, 26(8):1069-1075. (co-first author)